Study of Safety of Medicinal Products in Pregnant Women in Crimea
Journal: Safety and Risk of Pharmacotherapy
Year: 2021

According to international epidemiological studies, about 80% of women have to use medicinal products during pregnancy, mainly during the ﬁrst weeks of organogenesis in the case of an unplanned pregnancy, and for the treatment of chronic diseases or acute conditions developing during pregnancy. Speciﬁcity of pharmacokinetics and pharmacodynamics in pregnant women contributes to the development of adverse drug reactions (ADRs), many of which are serious and pose a threat to the life of the patien